Bilecik Seyh Edebali Universitesi
bilecik.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
45
Active
15
Phase 3
0
Total enrollment
5,390
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Botulinum Toxin-A | — | — | — | — | — | 1 |
Next readouts
- 2026-12-20
Top conditions
- Nursing Students6
- Nursing Education4
- Anxiety4
- Child, Only3
- Music Therapy2
- Education2
- Postoperative Pain2
- Breast Feeding2
Frequently asked questions about Bilecik Seyh Edebali Universitesi
- How many clinical trials does Bilecik Seyh Edebali Universitesi have on ClinicalTrials.gov?
- Bilecik Seyh Edebali Universitesi is listed as the lead sponsor on 45 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Bilecik Seyh Edebali Universitesi's trials are in Phase 3?
- 0 of Bilecik Seyh Edebali Universitesi's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Bilecik Seyh Edebali Universitesi focus on?
- Bilecik Seyh Edebali Universitesi's most-studied conditions on ClinicalTrials.gov are Nursing Students, Nursing Education, Anxiety, Child, Only, Music Therapy.
- When are Bilecik Seyh Edebali Universitesi's next clinical trial readouts?
- Bilecik Seyh Edebali Universitesi has 1 upcoming primary-completion readout tracked here; the soonest is “Botulinum Toxin-A for Bruxism Using Digital Occlusal Analysis”, expected around 2026-12-20.